FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Steps to Boost U.S. Drug Production

[ Price : $8.95]

FDA says it is starting the FDA PreCheck program to help drug companies develop manufacturing facilities in the U.S.

ICH Extractables, Leachables Guide

[ Price : $8.95]

FDA publishes a draft International Council on Harmonization guideline for extractables and leachables to solicit public comment.

Julie Tierney Joins Leavitt Partners

[ Price : $8.95]

Former FDAer Julie Tierney is now a principal in Leavitt Partners Washington office.

J&J Complete Response Letter on Darzalex Faspro

[ Price : $8.95]

FDA issues Johnson & Johnson a complete response letter for its supplemental BLA for Darzalex Faspro (daratumumab and hyaluronidas...

Instylla PMA Approved for Hypervascular Tumors

[ Price : $8.95]

FDA approves an Instylla PMA for its Embrace Hydrogel Embolic System, a liquid embolic device for treating hypervascular tumors in...

QS, MDR Issues at Taiwans Visgeneer

[ Price : $8.95]

FDA warns Taiwans Visgeneer, Inc., about Quality System and Medical Device Reporting violations in its manufacturing of blood gluc...

Medical Device PFAS Appear Safe: FDA

[ Price : $8.95]

FDA issues an online post describing the safety to patients of the type of PFAS used in medical devices.

BMS Files Breyanzi Marginal Zone Lymphoma sBLA

[ Price : $8.95]

FDA accepts for priority review a Bristol Myers Squibb supplemental BLA for Breyanzi (lisocabtagene maraleucel; liso-cel) as a pot...

Lantheus NDA for Pylarify New Formulation

[ Price : $8.95]

FDA accepts a Lantheus NDA for a new formulation of its Pylarify F 18 prostate-specific membrane antigen imaging agent.

Alert on Boston Scientific Defibrillation Leads

[ Price : $8.95]

FDA issues an early alert based on a Boston Scientific letter to customers about certain Endotak Reliance defibrillation leads tha...